BFM 89.9
The Business Station
Recommended
26 mins
23 mins
26 mins
Earlier this month, Malaysia’s Drug Control Authority granted conditional registration of a new drug to treat hepatitis C. This move was hailed by many as another step towards eliminating hepatitis C, making treatment both more affordable and accessible in low- and middle-income countries like Malaysia. Why was this hailed as a new milestone and how long will it take before we achieve a hepatitis-free world? We find out from Datuk Dr Muhammad Radzi Abu Hassan, National Head of Gastroenterology and Hepatology, Ministry of Health, and Jean-Michel Piedagnel, Director, Drugs for Neglected Diseases Initiative (DNDi) Southeast Asia.
Image source: Shutterstock
Presenter: Tee Shiao Eek
Producer: Lim Sue Ann
The Bigger PictureHealth & Livinghepatitis CHCVRavidasvirSofosbuvirdisease eliminationDrugs For Neglected Disease InitiativeDNDiantiviralsdirect-acting antivirals
Share:
Recommended
May 10
·
23 minsWhat It Takes To Get Your Bread Right
May 9
·
26 minsConfronting Bullying In The Workplace
Recent episodes
0
Latest stories
Podcasts · Jul 2 · 9:00AM
Top 5 at 5: The Future of Online Healthcare
43 mins
Podcasts · Jul 2 · 43 mins
Top 5 at 5: The Future of Online Healthcare
Podcasts · Jul 2 · 8:00AM
Humans of Healthcare: The Medical Social Worker
34 mins
Podcasts · Jul 2 · 34 mins
Humans of Healthcare: The Medical Social Worker
Podcasts · Jul 2 · 7:00AM
Saving Fireflies: Science, Stories and Solutions
39 mins
Podcasts · Jul 2 · 39 mins
Saving Fireflies: Science, Stories and Solutions